Search - tctmd.com

Displaying 181 - 200 of 571

Presentation TCT 2018

MVD Case Presentation With Heart Team Discussion, Case Introduction

Presenter: Antonio Colombo, Jeffrey W. Moses, Carlos Collet, Pablo Lamelas, John D. Puskas, Alfredo E. Rodriguez, Pieter C. Smits, Wilson Y. Szeto

September 22, 2018

Presentation TCT 2018

Hybrid Revascularization as an Alternative to PCI or CABG

Presenter: Antonio Colombo, Jeffrey W. Moses, John D. Puskas

September 22, 2018

Presentation TCT 2018

PCI for MVD: Is Complete Revascularization the Missing Link? Anatomic or Functional?

Presenter: Antonio Colombo, Jeffrey W. Moses, William F. Fearon

September 22, 2018

Presentation TCT 2018

How Much Has PCI (and CABG) Improved in MVD and LMD: Insights From SYNTAX II and SYNTAX-EXCEL Comparative Analyses

Presenter: Antonio Colombo, Jeffrey W. Moses, Patrick W. Serruys

September 22, 2018

Presentation TCT 2018

ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population

Presenter: Gregg W. Stone, Pieter R. Stella

September 22, 2018

Presentation TCT 2018

Mortality and Stroke Outcomes of PCI vs CABG in MVD and LMD With and Without Diabetes

Presenter: Antonio Colombo, Jeffrey W. Moses, Stuart J. Head

September 22, 2018

Presentation TCT 2018

Defining What Constitutes a Clinically Relevant Peri-Procedural MI: Analysis in > 17,000 Patients

Presenter: Antonio Colombo, Jeffrey W. Moses, Jung-Min Ahn

September 22, 2018

Presentation TCT 2018

PCI for Ischemia Part II: Why the ISCHEMIA Trial Might be Positive..or Negative!

Presenter: David J. Cohen, Sunil V. Rao, Ajay J. Kirtane

September 22, 2018

Presentation TCT 2018

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

Presenter: William A. Gray

September 22, 2018

Presentation TCT 2018

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Presenter: David J. Cohen, Sunil V. Rao, Bernard J. Gersh

September 22, 2018

Presentation TCT 2018

Increasing Emphasis on QOL Outcomes: From Patient Preference to Instrument Validation

Presenter: David J. Cohen, Sunil V. Rao, John A. Spertus

September 22, 2018

Presentation TCT 2018

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Presenter: David J. Cohen, Sunil V. Rao, David J. Maron

September 22, 2018

Presentation TCT 2018

Case Conclusion

Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini

September 22, 2018

Presentation TCT 2018

DAPT Duration Case Presentation #2: PCI in Stable CAD With LMCAD and MVD, Case Introduction

Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini

September 22, 2018

Presentation TCT 2018

DAPT Duration Case Presentation #1: NSTEMI in a High Bleeding Risk Patient, Case Introduction

Presenter: Philip M. Urban, Robert W. Yeh, Michael A. Kutcher, Michelle O'Donoghue, Elmir Omerovic, Manel Sabate, Daniel I. Simon, Giuseppe Tarantini

September 22, 2018

Presentation TCT 2018

Stent Selection for 1-3 Month DAPT: Current Evidence, Ongoing Studies

Presenter: Philip M. Urban, Robert W. Yeh, Stephan Windecker

September 22, 2018

Presentation TCT 2018

Algorithmic Pharmacology Recommendations for the PCI Patient With Atrial Fibrillation

Presenter: Philip M. Urban, Robert W. Yeh, C. Michael Gibson

September 22, 2018

Presentation TCT 2018

Latest Thinking on DAPT Duration: Balancing Risk vs Benefit

Presenter: Philip M. Urban, Robert W. Yeh, Tullio Palmerini

September 22, 2018

Presentation TCT 2018

Ultra-Thin Strut DES: A Meaningful Advance?

Presenter: Renu Virmani, Clemens von Birgelen, Sripal Bangalore

September 22, 2018

Presentation TCT 2018

Can Contemporary DES Be Improved by Altering the Drug, Polymer, Alloy or Construction?

Presenter: Renu Virmani, Clemens von Birgelen, David E. Kandzari

September 22, 2018

Advertisement

MVD Case Presentation With Heart Team Discussion, Case Introduction

Hybrid Revascularization as an Alternative to PCI or CABG

PCI for MVD: Is Complete Revascularization the Missing Link? Anatomic or Functional?

How Much Has PCI (and CABG) Improved in MVD and LMD: Insights From SYNTAX II and SYNTAX-EXCEL Comparative Analyses

ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population

Mortality and Stroke Outcomes of PCI vs CABG in MVD and LMD With and Without Diabetes

Defining What Constitutes a Clinically Relevant Peri-Procedural MI: Analysis in > 17,000 Patients

PCI for Ischemia Part II: Why the ISCHEMIA Trial Might be Positive..or Negative!

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Increasing Emphasis on QOL Outcomes: From Patient Preference to Instrument Validation

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Case Conclusion

DAPT Duration Case Presentation #2: PCI in Stable CAD With LMCAD and MVD, Case Introduction

DAPT Duration Case Presentation #1: NSTEMI in a High Bleeding Risk Patient, Case Introduction

Stent Selection for 1-3 Month DAPT: Current Evidence, Ongoing Studies

Algorithmic Pharmacology Recommendations for the PCI Patient With Atrial Fibrillation

Latest Thinking on DAPT Duration: Balancing Risk vs Benefit

Ultra-Thin Strut DES: A Meaningful Advance?

Can Contemporary DES Be Improved by Altering the Drug, Polymer, Alloy or Construction?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content